Braskem S.A. (BAK)
3.90
0.12 (3.17%)
At close: Jan 14, 2025, 3:59 PM
3.90
-0.13%
Pre-market Jan 15, 2025, 04:08 AM EST
undefined% (undefined)
| Bid | 3.72 |
| Market Cap | 1.53B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -3.01 |
| PE Ratio (ttm) | -1.3 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 3.9 |
| Volume | 807,001 |
| Avg. Volume (20D) | 903,168 |
| Open | 3.76 |
| Previous Close | 3.78 |
| Day's Range | 3.76 - 3.92 |
| 52-Week Range | 3.69 - 10.98 |
| Beta | undefined |
About BAK
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tert...
Industry Chemicals
Sector Basic Materials
IPO Date Jan 13, 1999
Employees 8,569
Stock Exchange NYSE
Ticker Symbol BAK
Website https://www.braskem.com.br
Analyst Forecast
According to 3 analyst ratings, the average rating for BAK stock is "Strong Buy." The 12-month stock price forecast is $9.75, which is an increase of 149.68% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
Braskem S.A. is scheduled to release its earnings on Mar 18, 2025,
before market opens.
Analysts project revenue of $3.65B, reflecting a 8.34% YoY growth and earnings per share of -0.26, making a -67.50% decrease YoY.
Analysts project revenue of $3.65B, reflecting a 8.34% YoY growth and earnings per share of -0.26, making a -67.50% decrease YoY.
3 months ago ·
Source
+5.21%
Braskem shares are trading higher after UBS upgrad...
Unlock content with
Pro Subscription
4 months ago ·
Source
-4.75%
Braskem SA shares are trading lower after JP Morgan lowered its price target on the stock from $10 to $9.5.
